Comparison between Curis Lifesciences IPO and Katex Exim IPO.
Curis Lifesciences IPO is a SME Fixed Price IPO proposed to list at NSE SME while Katex Exim IPO is a SME Fixed Price proposed to list at BSE SME.
Curis Lifesciences IPO | Katex Exim IPO | |
---|---|---|
Logo | ![]() | ![]() |
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Bookbuilding | Fixed Price |
Listing At | NSE SME | BSE SME |
Lead Managers | Swastika Investmart Ltd. | Nirbhay Capital Services Pvt.Ltd. |
Registrar | MUFG Intime India Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
Market Maker | ||
DRHP | DRHP ![]() | DRHP ![]() |
RHP | RHP ![]() | |
Anchor Investor | ||
IPO Allotment URL |
The total issue size of Curis Lifesciences IPO is up to ₹0.00 Cr whereas the issue size of the Katex Exim IPO is up to ₹0.00 Cr. The final issue price of Curis Lifesciences IPO is and of Katex Exim IPO is .
Curis Lifesciences IPO | Katex Exim IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ||
Issue Price (Upper) | ||
Issue Price (Final) | ||
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | ||
Fresh Issue Size | 22,50,000 shares | 66,00,000 shares |
Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
OFS Issue Size | 0 shares | 0 shares |
OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Issue Size Total | 22,50,000 shares | 66,00,000 shares |
Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Curis Lifesciences IPO opens on , while Katex Exim IPO opens on . The closing date of Curis Lifesciences IPO and Katex Exim IPO is , and , respectively.
Curis Lifesciences IPO | Katex Exim IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | ||
Issue Close | ||
Basis Of Allotment (Tentative) | ||
Initiation of Refunds (Tentative) | ||
Credit of Share (Tentative) | ||
Listing date (Tentative) | ||
Anchor Lockin End date 1 | ||
Anchor Lockin End date 2 |
Curis Lifesciences IPO P/E ratio is , as compared to Katex Exim IPO P/E ratio of .
Curis Lifesciences IPO | Katex Exim IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financials | Curis Lifesciences Limited Financial Information (Restated)
| Katex Exim Limited Financial Information (Restated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 92.68 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 145.20% | 26.39% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 34.89% | 13.67% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 2.86 | 3.48 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 84.12% | 23.37% |
In the Curis Lifesciences IPO Retail Individual Investors (RII) are offered 0 shares while in Katex Exim IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Curis Lifesciences IPO and in Katex Exim IPO.
Curis Lifesciences IPO | Katex Exim IPO | |
---|---|---|
Anchor Investor Reserveration | 0 shares | |
Market Maker Reserveration | 0 shares | 3,32,000 shares |
QIB | 0 shares | |
NII | 0 shares | |
RII | 0 shares | |
Employee | 0 shares | |
Others | ||
Total | 0 shares |
Curis Lifesciences IPO subscribed in total, whereas Katex Exim IPO subscribed .
Curis Lifesciences IPO | Katex Exim IPO | |
---|---|---|
QIB (times) | ||
NII (times) | ||
Big NII (times) | ||
Small NII (times) | ||
RII (times) | ||
Employee (times) | ||
Other (times) | ||
Total (times) |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O